JP2024513394A5 - - Google Patents

Info

Publication number
JP2024513394A5
JP2024513394A5 JP2023560507A JP2023560507A JP2024513394A5 JP 2024513394 A5 JP2024513394 A5 JP 2024513394A5 JP 2023560507 A JP2023560507 A JP 2023560507A JP 2023560507 A JP2023560507 A JP 2023560507A JP 2024513394 A5 JP2024513394 A5 JP 2024513394A5
Authority
JP
Japan
Prior art keywords
formula
compound
stereoisomer
salt
chiral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513394A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/022997 external-priority patent/WO2022212809A1/en
Publication of JP2024513394A publication Critical patent/JP2024513394A/ja
Publication of JP2024513394A5 publication Critical patent/JP2024513394A5/ja
Pending legal-status Critical Current

Links

JP2023560507A 2021-04-02 2022-04-01 二環式ケトン化合物を作製するための方法 Pending JP2024513394A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163170422P 2021-04-02 2021-04-02
US63/170,422 2021-04-02
PCT/US2022/022997 WO2022212809A1 (en) 2021-04-02 2022-04-01 Processes for making bicyclic ketone compounds

Publications (2)

Publication Number Publication Date
JP2024513394A JP2024513394A (ja) 2024-03-25
JP2024513394A5 true JP2024513394A5 (enExample) 2025-03-31

Family

ID=81385014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560507A Pending JP2024513394A (ja) 2021-04-02 2022-04-01 二環式ケトン化合物を作製するための方法

Country Status (13)

Country Link
US (1) US20240034739A1 (enExample)
EP (1) EP4313986A1 (enExample)
JP (1) JP2024513394A (enExample)
KR (1) KR20230165238A (enExample)
CN (1) CN117098762A (enExample)
AR (1) AR125294A1 (enExample)
AU (1) AU2022246900A1 (enExample)
BR (1) BR112023020229A2 (enExample)
CA (1) CA3214802A1 (enExample)
IL (1) IL307250A (enExample)
MX (1) MX2023011482A (enExample)
TW (1) TW202304921A (enExample)
WO (1) WO2022212809A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026139459A1 (en) 2024-12-23 2026-07-02 Astrazeneca Ab Heterocyclic inhibitors of ripk1

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3155107B2 (ja) 1993-01-12 2001-04-09 ダイセル化学工業株式会社 光学活性4−ハロ−3−ヒドロキシ酪酸エステルの製造方法
JPH08336393A (ja) 1995-04-13 1996-12-24 Mitsubishi Chem Corp 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
JP3915015B2 (ja) 1995-08-22 2007-05-16 味の素株式会社 光学活性2−ヒドロキシ−4−アリール酪酸またはそのエステルの製造方法
CA2234913A1 (en) * 1995-10-18 1997-04-24 Paul E. Finke Cyclopentyl tachykinin receptor antagonists
US5891685A (en) 1996-06-03 1999-04-06 Mitsubishi Chemical Corporation Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid
DE19857302C2 (de) 1998-12-14 2000-10-26 Forschungszentrum Juelich Gmbh Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester
AU1551701A (en) 1999-12-03 2001-06-12 Kaneka Corporation Novel carbonyl reductase, gene thereof and method of using the same
AU2007201854A1 (en) * 2000-10-17 2007-05-17 Merck Serono Sa Pharmaceutically active sulfanilide derivatives
HUP0400261A3 (en) 2001-03-22 2005-11-28 Bristol Myers Squibb Co Stereoselective reduction of substituted acetophenone
US20080050787A1 (en) 2003-12-02 2008-02-28 Hazuki Nagai Method for Manufacturing Optically Active Tetrahydrothiophene Derivative and Method for Crystallization of Optically Active Tetrahydrothiophene-3-Ol
WO2006130657A2 (en) 2005-05-31 2006-12-07 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
CN101627116B (zh) 2007-02-08 2013-07-10 科德克希思公司 酮还原酶及其用途
JP2010070502A (ja) * 2008-09-19 2010-04-02 Daiichi Sankyo Co Ltd 抗真菌作用トリアゾロピリジン誘導体
RU2515976C2 (ru) * 2009-02-26 2014-05-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Азотсодержащие конденсированные гетероциклические соединения и их применение в качестве ингибиторов продукции бета-амилоида
TWI648274B (zh) 2013-02-15 2019-01-21 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺類 (二)
RU2716136C2 (ru) 2015-07-02 2020-03-06 Ф. Хоффманн-Ля Рош Аг Бициклические лактамы и способы их применения
US11071721B2 (en) * 2016-12-02 2021-07-27 Genentech, Inc. Bicyclic amide compounds and methods of use thereof
CN119613408A (zh) * 2017-07-14 2025-03-14 豪夫迈·罗氏有限公司 二环酮化合物及其使用方法
WO2019072942A1 (en) * 2017-10-11 2019-04-18 F. Hoffmann-La Roche Ag BICYCLIC COMPOUNDS FOR USE AS INHIBITORS OF KINASE RIP1
CN113302193B (zh) * 2019-01-11 2026-05-29 豪夫迈·罗氏有限公司 双环吡咯并三唑酮化合物及其使用方法
CN111606890A (zh) * 2019-02-26 2020-09-01 微境生物医药科技(上海)有限公司 含丙烯酰基的核转运调节剂及其用途

Similar Documents

Publication Publication Date Title
JP5513508B2 (ja) アミノスルホン化合物を調製するためのプロセス
TWI694982B (zh) 3-側氧基-3-(芳基胺基)丙酸酯,其製備程序,及其於製備吡咯酮的應用
RU2016133187A (ru) Способ получения n-[(3-аминооксетан-3-ил)метил]-2-(1,1-диоксо-3,5-дигидро-1,4-бензотиазепин-4ил)-6-метил-хиназолин-4-амина
JP2021523225A5 (enExample)
CN102414202B (zh) 制备取代异噁唑啉化合物及其前体的方法
JP2008523069A5 (enExample)
CN106661052B (zh) 头孢菌素衍生物的中间体及其制造方法
JP2021512163A5 (enExample)
WO2022137370A1 (ja) スルホン誘導体の製造方法
CN104718216B (zh) 制备头孢洛林酯的新方法
CN106458901A (zh) 用于制备稠合杂环化合物的方法
CN117813304A (zh) 用于制备阿夫凯泰的方法
JPWO2019208643A5 (enExample)
US9688657B2 (en) Synthesis of dabigatran
CN110028451B (zh) 一种全取代吡唑衍生物制备方法
JP2009504800A5 (enExample)
JP7311520B2 (ja) スルフェントラゾンの合成のための方法
JP4208464B2 (ja) ナフチリジン−3−カルボン酸誘導体の製造法
JP5140776B1 (ja) 1−置換−3−フルオロアルキルピラゾール−4−カルボン酸エステルの製造方法
JP6809485B2 (ja) 酸ハライド溶液の製造方法、及びモノエステル化合物の製造方法
WO2010098396A1 (ja) フェニル置換複素環誘導体の製造方法
JP2008500317A5 (enExample)
CN108026017B (zh) 酰卤溶液的制造方法、混合溶液及单酯化合物的制造方法
TW201307295A (zh) 咪唑衍生物的製造方法
US11053220B2 (en) Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline